CAMS Lab to Market: Turning Research into Real-World Impact

Meet Our Speakers  

Liqun Yang

Liqun obtained a BEng and MEng on Metrology and Instrumentation in Harbin Institute of Technology in China and a PhD in novel biophotonic sensing technology at King's College London.  After completion of a 3-year post-Doc fellowship on optoelectronic sensing investigation at RGU, he joined GlaxoSmithKline R&D in 1996, where he functioned as an in-house technology consultant, providing technology innovation support to R&D scientists across drug R&D.  His key remit in the company include to identify, evaluate, and transfer emerging disruptive technology into the company to address company's technology needs in drug R&D, particularly on sensors, measurement, and instrumentation related innovations.  After serving appr. 9 years at Glaxo, he spends following 3 in start-up companies, working on developing novel sensing technologies for oil & gas industry and for biopharmaceutical measurements.  In 2008, Liqun returned to work on knowledge exchange and knowledge transfer functions in UK universities, as a Research and Enterprise Manager at University of Essex and a Business Development Manager at King’s College London. In those functions his main responsibilities include managing KT/KE programme, facilitating and supporting academics in develop KE/KT projects, collaborations with industry, and other research commercialization activities. Liqun joined the sensor system team at Innovate UK Business Connect (known as KTN Ltd) in November 2014, and now a KTM-Enabling Technologies in Emerging and Enabling Technology Team.

Damion Corrigan

Professor Damion Corrigan FRSC is the LGC Professor in Measurement Science for Health at the University of Strathclyde and leads the Centre for Advanced Measurement Research and Health Translation, a partnership with NML and NHS Lanarkshire. His research develops electrochemical diagnostic technologies for healthcare applications, spanning antimicrobial resistance, cancer and cardiovascular disease. An award-winning academic entrepreneur, he co-founded Aureum Diagnostics and Microplate Dx and works closely with clinical, industrial and scientific partners.

 Stuart Angell

Stuart Angell is a regulatory affairs expert and industry leader with more than 25 years of experience in the in vitro diagnostics (IVD) sector. He specialises in UK and EU medical device and IVD regulations, regulatory strategy, market access, quality systems, and compliance. Stuart serves on the Director of Regulatory and Executive Board member of the British In Vitro Diagnostics Association (BIVDA), where he works closely with regulators, policymakers, and industry stakeholders to shape the future of diagnostic regulation. 

David Havelin

David Havelin is a Commercialisation and Spin-Out Specialist with Enterprise Ireland, where he supports the translation of research and innovation into commercial opportunities. Working within the ICT sector, he collaborates with universities, researchers and technology-focused organisations to identify high-potential innovations, support spin-out creation and accelerate the commercialisation of research. Through his role, he helps connect innovators with funding, expertise and industry networks, enabling the development and growth of technology-driven ventures and contributing to Ireland’s innovation ecosystem.